{{Rsnum
|rsid=9580312
|Chromosome=13
|position=22179954
|Orientation=plus
|GMAF=0.2287
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 67.3 | 32.7 | 0.0
| HCB | 30.7 | 55.5 | 13.9
| JPT | 40.7 | 48.7 | 10.6
| YRI | 80.3 | 19.7 | 0.0
| ASW | 73.2 | 23.2 | 3.6
| CHB | 30.7 | 55.5 | 13.9
| CHD | 43.1 | 42.2 | 14.7
| GIH | 40.6 | 41.6 | 17.8
| LWK | 83.6 | 13.6 | 2.7
| MEX | 44.8 | 44.8 | 10.3
| MKK | 81.4 | 17.9 | 0.6
| TSI | 66.7 | 28.4 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=8E-6
  |OR=1.33
  |ORtxt=[1.12-1.581]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}